Cost-effectiveness of routine influenza vaccination program for individuals aged 65 years and older in Japan: Substituting standard-dose inactivated vaccine with high-dose inactivated vaccine
For a WTP of JPY 5,000,000/US$ 33,333 per QALY gained, if the price of HD was four times the current vaccine, the seasonal HD-IIV3 vaccination program was not cost-effective for those aged ≥65 years, while was cost-effective for those aged ≥75 years.
Authors
- Shu-Ling Hoshi
- Xerxes Seposo
- Masahide Kondo
Institutions
- University of Tsukuba (JP)
- Hokkaido University (JP)
- Tsukuba University of Technology (JP)
Publication Details
- Journal
- IJID Regions
- Published
- 2026-02-14
- DOI
- https://doi.org/10.1016/j.ijregi.2026.100858
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00